Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) -28.1515.1660.74-30.36-23.03

What is the latest Core EBITDA Growth ratio of PIRAMAL PHARMA ?

The latest Core EBITDA Growth ratio of PIRAMAL PHARMA is -28.15 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar2026-28.15
Mar202515.16
Mar202460.74
Mar2023-30.36
Mar2022-23.03

How is Core EBITDA Growth of PIRAMAL PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2026 -28.15
Negative
Mar2025 15.16
-75.04
Mar2024 60.74
Positive
Mar2023 -30.36
Negative
Mar2022 -23.03 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Core EBITDA Growth ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹26,419.6 Cr 3.9% -4.7% -0.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,283.0 Cr 0.9% -5% 3.2% Stock Analytics
DIVIS LABORATORIES ₹251,611.0 Cr 3.6% -1.4% 37.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹175,182.0 Cr 1.7% -6.7% 28% Stock Analytics
CIPLA ₹109,063.0 Cr 2.8% -3.9% -17.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,926.0 Cr 5.4% 8.7% 1.6% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

3.9%

-4.7%

-0.1%

SENSEX

-0.3%

-1.6%

-12.3%


You may also like the below Video Courses